BPC-157 + TB500 (Blend)

What is the peptide mix of BPC-157 + TB-500?

BPC-157 + TB-500 is a combined research peptide blend combining two well-known peptides for convenience and synergistic action. The formula is the subject of research aimed at recovery processes, tissue regeneration, and supporting physical recovery after exertion or injuries.

Active ingredients and mechanism of action:

BPC-157

BPC-157 is a bioactive peptide associated with tissue protection and recovery processes. It has been studied for its potential to support the regeneration of muscles, tendons, joints and nerve tissue, as well as for its association with processes related to local blood supply and the inflammatory response.

TB-500

TB-500 is a synthetic peptide mainly studied in the context of recovery after injuries and surgical interventions. It participates in processes related to cell migration and regeneration, with interest in it directed at tendons, muscles, bones, skin and joints. In research settings TB-500 is also associated with anti-inflammatory potential and improvement of mobility.

Potential benefits of the BPC-157 + TB-500 combination:

The combination of the two peptides is regarded as a synergistic formula with a wide range of possible applications in a research context, including:

• supporting recovery after physical exertion or injuries
• stimulating regeneration of muscle, tendon and connective tissue
• support for inflammatory processes
• improving mobility and the functionality of joints
• support for skin regeneration and tissue healing
• overall support of physical conditioning and recovery processes

Clinical and research data:

BPC-157 and TB-500 are the subject of numerous preclinical and clinical studies focused on tissue recovery, the inflammatory response and regenerative processes. Interest in combining them stems from the different but complementary mechanisms of action that could potentially enhance the overall recovery effect.

Administration and dosage 

In a research context the BPC-157 + TB-500 blend is used in a daily range of 250 micrograms to 400 micrograms for a period of up to 2 months. The data reflect doses applied solely in research protocols.

Possible side effects

According to available research data the BPC-157 + TB-500 blend is characterized by good tolerability. Reported adverse reactions are rare and usually mild, and may include:

• temporary local discomfort
• short-term sensitivity at the application site

As with all research peptides, the product is not intended for medical use and should be used only in a research context.